GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.
ILLUSTRATION 3 |MISSION AND STRATEGY
Our mission: One is to innovate. The other one is to differentiate. The other one is to accelerate and finally...
Adding GeoVax (GOVX) $3.32 to Reverse Stock Split Watch List.
Okay, Here's Our First Name for the Reverse Stock Split, Watch List. We'll Venture to Have 10 Names Added to Watch List Within 30...
Ardelyx (ARDX), Raymond James up Price Target, Citigroup Joins the Party.
Wall Street Cozy's up to Ardelyx After New Guidance.
On January 8th, Mike Raab, President and Chief Executive Officer stated, "We consistently grew sales of...
Is David Dodd on to his Next Billion Dollar Payday for Shareholders?
Huge News: Gedeptin® Therapy Demonstrated Safety, Stabilization and Shrinkage of Treated Tumors.
GeoVax (GOVX) Completes Patient Enrollment for Head & Neck Cancer Drug, Gedeptin.®
David...
Pharmather (PHRRF) Has Officially Broken Out.
Read Corporate Presentation Today.
Pharmather (PHRRF) which we gave a 'heads-up,' because looked like it was about to break above resistance last week, has soundly...
Adding Geovax (GOVX) to 2024 Biotech Watch List.
GEOVAX (GOVX) $0.32
We added this to the Watch List earlier in the week and then AFTER speaking to CEO David Dodd and the Head...
GeoVax Labs (GOVX) Video Presentation.
GeoVax’s COVID-19 vaccine candidates, which can induce strong antibody and T cell responses against the variants of the SARS-CoV-2 virus, also offers the possibility...
Two That Doubled and Now Look Ready to Break Out.. and a Third That...
We are up 234% in Ardelyx (ARDX) $5.23 since adding it to Watch List a year ago and up 71% in Cardiol Therapeutics (CRDL)...
Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.
Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003...
Adding GeoVax (GOVX) $0.52 to Watch List.
Report Out Next Week. Head's Up.
Price and time-stamping our returning interest at $0.52.
We're headed to the Dawson James Investor Conference tomorrow to see...
Latest article
Report III: A Deeper Dive Into the Nutriband’s (NTRB) $200 Million Revenue Estimate.
Look at the Basic Math and Decide for Yourself.
Click Here to Open
News coverage and reporting client. See report for full disclosure and disclaimer details.
Standard...
Report II: Updating Coverage on Nutriband (NTRB) $7.77.
Hmm. The number 777 is commonly interpreted as a sign of spiritual alignment, good fortune. Let's hope these revenue forecasts are on the money!...
Pan Global Resources (PGZ) Investor Presentation.
Pan Global Resources (PGZ, PGZFF) a Proven Ground Exploration company, will doing a non-deal roadshow in the Palm Beach Area tonight. We'll attend and...
